| Controls | T2D | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
MODEL 1 | ||||||
Age, years | 1.04 | 1.01–1.07 | 0.02 | 1 | 0.94–1.02 | 0.29 |
Male sex | 2.4 | 1.01–5.7 | 0.04 | 1.7 | 0.6–4.7 | 0.34 |
BMI, kg/m2 | 1 | 0.93–1.11 | 0.67 | 1.1 | 0.96–1.17 | 0.25 |
CATi, mL/m2 (continuous) | 1 | 0.99–1.004 | 0.34 | 1.01 | 1.003–1.02 | 0.005 |
MODEL 2 | ||||||
CATi, mL/m2 (continuous) | 1 | 0.99–1.01 | 0.6 | 1.01 | 1.003–1.02 | 0.005 |
Dyslipidemia | 1.7 | 0.7–4.3 | 0.3 | 3.7 | 1.4–10.2 | 0.008 |
CRP, mg/L | 1 | 0.999–1.001 | 0.09 | 1 | 0.998–1.01 | 0.1 |
CAC DRS = 3 or < 3 | 2.5 | 0.6–11 | 0.2 | 0.5 | 0.2–1.5 | 0.2 |
MODEL 3 | ||||||
CATi > 100 mL/m2 (dichotomous) | 0.6 | 0.3–1.4 | 0.3 | 4.6 | 1.6–14 | 0.004 |
Dyslipidemia | 1.8 | 0.7–4.5 | 0.2 | 3.8 | 1.4–10 | 0.007 |
CRP, mg/L | 1 | 0.999–1.01 | 0.1 | 1 | 0.998–1.01 | 0.1 |
CAC DRS = 3 or < 3 | 2.5 | 0.6–12 | 0.2 | 0.5 | 0.2–1.5 | 0.2 |